Proteases secreted by Aspergillus fumigatus induce the production of cytokines by epithelial cells, including interleukin (IL)-6 and IL-8. In the present study, we focused on the mechanism(s) by which A. fumigatus-derived proteases elicit cytokine production in epithelial cells. In the epithelial cell line A549, IL-6 and IL-8 mRNA levels were enhanced by proteases as a result of transcriptional induction of the respective genes. Transcriptional induction of both genes coincided with enhanced DNA binding of nuclear factor (NF)-kB and NF-IL6, whereas activator protein-1 was unlikely to be involved. The enhanced transcriptional activity could be inhibited by the addition of chymostatin, showing serine protease dependency. Posttranscriptional mechanisms affecting the stability of IL-6 and IL-8 mRNAs were not involved in protease-induced IL-6 and IL-8 production. These data show that after exposure to A. fumigatus-derived proteases, IL-6 and IL-8 gene expressions are up-regulated as a result of transcriptional mechanisms.
duce the release of proinflammatory cytokines from epithelial cells [10] [11] [12] . Recently, it has become evident that A. fumigatus-derived extracellular proteases are able to induce the production of proinflammatory cytokines by the epithelial cell lines A549 end H292, such as interleukin (IL)-6, IL-8, and monocyte chemotactic protein-1 [13] . In the present study, we focused on the mechanism(s) by which A. fumigatus-derived proteases elicit proinflammatory cytokine production in human epithelial cell lines.
Materials and Methods
A. fumigatus culture filtrates. Preparation of culture filtrates from early-phase A. fumigatus cultures in collagen-yeast carbon base medium (early-phase collagen culture filtrate [EColCF]) was performed as described elsewhere [13] . Elastase activity was quantified by using the elastase-specific substrate N-succinyl-alanylalanyl-prolyl-leucine p-nitroanilide (Sigma, St. Louis). Substrate (final concentration, 2.5 mM) was added to EColCF (final concentration, 0.33 mg protein/mL) in buffer (100 mM Tris-HCl, 200 mM NaCl, 0.05% Triton X-100, pH 7.8) in a 96-well, flat-bottomed microtiter plate (Greiner Labortechnik, Alphen a/d Rijn, The Netherlands) at 37ЊC. The A 405 was read every 30 s for 5 min with a computerized plate reader (Thermomax; Sopar-Biochem, Nieuwegein, The Netherlands). One unit of elastase activity is defined as the amount of enzyme that results in an increase of 1 optical density unit (A 405 ) per minute. Total protease and gelatinase activities were measured according to the methods described elsewhere [13] , by using casein (Merck, Darmstadt, Germany) and orange gelatine (BIOK, Vilnius, Lithuania) as substrates, respectively. One unit of enzyme activity is the amount of enzyme that hydrolyzes 1 mg of casein (total protease activity) or 1 mg of orange gelatin (gelatinase activity) in 30 min. When protease inhibitors were used, EColCF was incubated with the inhibitors for 15 min at 37ЊC before being added to the cells. Chymostatin (10 mg/mL) and antipain (10 mg/mL) were used as protease inhibitors.
Cell cultures. The human alveolar type II epithelium-like cell line A549 was obtained from American Type Culture Collection (Rockville, MD). Cells were cultured at 37ЊC in RPMI 1640 (Life Technologies, Breda, The Netherlands) with 10% heat-inactivated fetal calf serum (Bio Whittaker, Verviers, Belgium) and 50 mg/mL gentamicin sulfate (Centafarm Services, Etten-Leur, The Netherlands). Epithelial cells were cultured in sterile 24-well culture dishes (Costar, Cambridge, MA) until 80%-90% confluence was reached. After overnight incubation in serum-free RPMI 1640, epithelial cell cultures were washed and incubated for 24 h with an optimal concentration of EColCF (5 mg/mL) [11] in serum-free RPMI 1640 at 37ºC and 5% CO 2 . A549 cells incubated with IL-1b (20 U/mL; Sanvertech, Breda, The Netherlands) served as positive control, whereas A549 cells incubated with medium alone served as negative control.
Extraction of mRNA and Northern analysis. Total cellular RNA was isolated by the guanidinum isothiocyanate/cesium chloride method [14] or by the single-step method as described by Chomczynski and Sacchi [15] . Total RNA (15 mg) was electrophoresed in 2.2 M formaldehyde, 1.1% agarose gels, and blotted onto nylon membranes (Hybond N ϩ ; Amersham, Amersham, UK) [16] . cDNA probes were labeled with [a-32 P]dCTP (3000 Ci/M; Amersham) by the random hexamer priming method [17] . The following cDNA probes were used: the 1.2-kb EcoRI insert of human IL-8 cDNA purified from the pcD-IL-8 plasmid (gift from Dr. J. J. Oppenheim, National Cancer Institute, Frederick, MD) and the EcoRI linearized pBR322 plasmid containing a 7.8-kb human 28S cDNA insert. Hybridization was performed at 65ЊC for 18 h in 0.5 M Na 2 HPO 4 , pH 7.2, 1 mM EDTA, 7% sodium dodecyl sulfate (SDS). Membranes were washed once in 2ϫ SSC (17.53 g/L NaCl, 8.82 g/L Na-citrate, pH 7.0), 0.1% SDS; once in 1ϫ SSC, 0.1% SDS; and finally in 0.3ϫ SSC, 0.1% SDS for 20 min at 65ЊC. The membranes were exposed to Kodak X-omat XAR films (Eastman Kodak, Rochester, NY) at Ϫ80ЊC by use of an intensifying screen. Quantification of mRNA levels was performed by densitometry by using a Gel Scan laser densitometer (Pharmacia, Uppsala, Sweden).
Reverse transcription (RT). Total cellular RNA isolated from A549 cells was isolated by use of the method described by 6 5 ϫ 10 Chomczynski and Sacchi [15] . Next, 5 mg of total cellular RNA was resuspended in 15 mL diethyl-pyrocarbonate (Sigma)-treated H 2 O and incubated at 68ЊC for 10 min. After cooling on ice, the samples were spun briefly in a microcentrifuge. Next, 10 mL of 10ϫ RT mix (135 mM Tris-HCl, pH 8.3, 204 mM KCl, 27 mM MgCl 2 , 0.24 mg/mL BSA, 5.4 mM each of dNTP, 14.3% glycerol) and 3 units of reverse transcriptase (Promega, Madison, WI) were added to the samples. The samples were spun briefly and incubated at 37ЊC for 60 min.
Polymerase chain reaction (PCR).
The following specific primer pairs for b-actin, IL-6, and IL-8 were obtained from Life Technologies. b-actin: 5 CCAGCAGAGAATGGAAAGTC 3 (sense) and 5 GATGCTGCTTACATGTCTCG 3 (antisense); IL-6: 5 -TCAATGAGGAGACTTGCCTG-3 (sense) and 5 -GATGAG-TTGTCATGTCCTGC-3 (antisense); and IL-8: 5 -TTGGCA-GCCTTCCTGATT-3 (sense) and 5 -AACTTCTCCACAACCC-TCTG-3 (antisense).
Semiquantitative PCR was performed for 20 cycles for b-actin, 25 cycles for IL-8, and 32 cycles for IL-6, as described elsewhere [18] . With these primers, fragments spanning 260, 247, and 280 bp were amplified for IL-6, IL-8, and b-actin, respectively. The final PCR products were run on a 1.5% agarose gel and blotted onto nylon membranes (Boehringer, Mannheim, Germany). IL-6, IL-8, and b-actin were detected by Southern hybridzation with specific DIG-labeled mRNA probes, as described elsewhere [19] . Levels of IL-6 and IL-8 PCR product were normalized with respect to the b-actin signal by use of a PhosphorImaging system and the ImageQuant software (Molecular Dynamics, Sunnyvale, CA). Electrophoretic mobility shift assay. After overnight culture in serum-free RPMI 1640, A549 cells were stimulated and nuclear extracts were prepared according to the miniscale procedure described elsewhere [18] . Nuclear extracts were divided into small aliquots and stored at Ϫ80ЊC. Double-stranded synthetic oligonucleotide probes containing the NF-kB consensus sequences (NFkB: 5 -AGCTGCGGGGATTTTCCCTG-3), the NF-IL6 consensus sequence (NF-IL6: 5 -AGTCGCGTTGTGCAATCTG-3), and the activator protein (AP)-1 consensus sequence (AP-1: 5 -AGC-TGCGTGACTCAGCTG-3) were used in the gel retardation assay. The consensus sequence for binding of these transcription factors are underlined.
The oligonucleotides were labeled with [g 32 P] ATP (3000 Ci/ mmol, Amersham), and the electophoretic mobility shift assay was performed as described elsewhere [18] . Quantification of protein binding was performed by densitometry by using a PhosphoImaging system (Molecular Dynamics).
Transient transfection assays. The luciferase reporter plasmids pIL6luc(Ϫ602), pIL6luc(Ϫ298), and pIL6luc(Ϫ122), containing various portions of the human IL-6 promoter cloned into the pGL 2 luciferase reporter vector (Promega, Madison, WI) or a luciferase reporter plasmid for the human IL-8 promoter (gift from Dr. N. Mukaida, Kanazawa University, Japan) were transfected into the A549 cell line. Prior to transfection, cells were cultured to approximately 70% confluency in the appropriate medium, washed twice, and resuspended in RPMI 1640. Transfections were performed with 5 mg of one of the after reporter plasmids: pIL6luc(Ϫ602), pIL6luc(Ϫ298), pIL6luc(Ϫ122), pIL6luc( mut NFkB), and pIL6( mut NF-IL6). Cotransfections with 1 mg of the expression plasmid pRSV-CAT were performed to determine transfection efficiencies. All transfections were done with the Fugene transfection kit (Boehringer) as recommended by the manufacturer. Twenty-four hours after transfection, cells were stimulated for 18 h with medium or an optimal concentration of EColCF (5 mg/mL). The cells were then harvested and lysed by commercially available luciferase lysis buffer. One hundred microliters of lysis product was added to 100 mL of luciferase assay reagents, and luciferase activity was measured with the Anthos Lucy1 luminometer (Anthos Labtec Instruments, Salzburg, Austria).
IL-6 and IL-8 protein analysis. IL-6 and IL-8 protein production by A549 cells (10 6 ) was quantified by using a commercially available ELISA kits, as recommended by the manufacturer (Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands). Vitality of cells was controlled microscopically by incubating the cells with trypan blue (0.2% in 0.9% NaCl).
Statistics. Statistical analysis was performed by use of Student's t test for paired observations, after checking for normal (open bars) and IL-8 (hatched bars) proteins were related to spontaneously produced protein levels (1.0). Both 1 and 5 mg/mL early-phase collagen culture filtrate (EColCF) significantly enhanced IL-6 and IL-8 protein levels ( , * ). The protease-dependent induction n = 6 P ! .001 of IL-6 and IL-8 is shown by the protease inhibitors chymostatin (10 mg/mL) and antipain (10 mg/mL). distribution of the data. Differences were considered significant if . Values are expressed as and are derived from P ! .05 mean ‫ע‬ SE at least 4 different experiments.
Results
Proteases from A. fumigatus enhance the expression of IL-6 and IL-8 mRNA and protein production by A549 cells. In agreement with our previous study [13] , EColCF enhanced the production of IL-6 and IL-8 protein by A549 cells dose dependently. A concentration of 5-10 mg/mL EColCF induced maximal IL-6 protein levels. In this study, 5 mg/mL EColCF was used in all described experiments. To reconfirm that the EColCF-induced IL-6 and IL-8 protein secretion is a proteasedependent process [13] , EColCF was incubated for 15 min with the protease inhibitors chymostatin or antipain. As shown in figure 1, EColCF-induced protein productions could be significantly inhibited by these protease inhibitors. To exclude any autocrine effects of soluble products of the A549 cells on IL-6 and IL-8 accumulation, protein levels were also analyzed in the absence of EColCF. IL-6 and IL-8 protein levels did not significantly change after 24 h of incubation with medium alone (data not shown).
The kinetics of IL-6 and IL-8 mRNA accumulation in A549 cells is shown in figure 2 . Low levels of IL-6 and IL-8 mRNA are constitutively present in unstimulated A549 cells. After 6 h of stimulation with EColCF, both IL-6 and IL-8 mRNA levels were significantly enhanced. The highest mRNA levels were present after у12 h of stimulation.
Proteases from A. fumigatus enhance the expression of IL-6 and IL-8 by transcriptional mechanisms. To analyze whether the observed up-regulatory effect of EColCF on IL-6 and IL-8 protein production is mediated at the transcriptional level, transient transfection experiments were performed. For this purpose, A549 cells were cotransfected with the pIL6luc(Ϫ602) promoter construct or with the pIL8luc(Ϫ546) promoter construct (containing a luciferase reporter gene driven by the IL- and presence (triangles) of 5 mg/mL EColCF. mRNA levels were determined by the reverse transcription-polymerase chain reaction (PCR) method at various times (indicated in minutes). PCR products were blotted onto nylon membranes and IL-6 and IL-8 levels were detected by Southern hybridzation with specific DIG-labeled mRNA probes. IL-6 and IL-8 mRNA half-lives were determined after normalization with respect to the b-actin levels. The experiment shown is representative of 3 independent experiments. Epithelial A549 cells were transiently transfected with the pIL6luc(Ϫ602) promoter construct or with the pIL8luc(Ϫ546) promoter construct (containing a luciferase reporter gene driven by the IL-6 or IL-8 promoter, respectively). Then the cells were incubated with medium alone (control) and with 5 mg/mL EColCF in the absence and presence of the protease inhibitor chymostatin (10 mg/mL). The bar diagram represents relative transcription rates, which were calculated after normalization to the respective levels of the cotransfected CAT activity. (*, ; #, ). P ! .002 P ! .001 6 or IL-8 promoter, respectively), together with pRSV(CAT) into A549 cells. Next, the cotransfected A549 cells were stimulated with control medium (RPMI 1640) and medium containing EColCF for 20 h. Relative IL-6 and IL-8 promoter activities were determined by measuring the luciferase activity in lysed A549 cells and are shown in figure 3 . The relative IL-6 promoter activity significantly increased when A549 cells were cultured in the presence of EColCF ( , , 2.01 ‫ע‬ 0.05 n = 6 P ! ), compared with control cells. Similarly, in the presence of .002 EColCF IL-8 promoter activity significantly increased, to ( , ). The addition of chymostatin to 2.75 ‫ע‬ 0.14 n = 4 P ! .001 the medium completely abrogated EColCF-induced IL-6 and IL-8 promoter activation, showing that transcriptional mechanisms are involved in protease-induced production of IL-6 and IL-8.
To investigate whether EColCF is able to modulate IL-6 mRNA at the posttranscriptional level, mRNA stability studies were performed. A549 cells were stimulated with medium alone and with medium containing EColCF (5 mg/mL). After 12 h of stimulation, actinomycin D was added (10 mg/mL) to prevent the synthesis of new RNA. Then total cellular RNA was harvested at different time points (figure 4). As demonstrated, IL-6 mRNA decayed with a t ½ of approximately 90 min. In the presence of EColCF, the t ½ of IL-6 mRNA decay was not affected. The t ½ of IL-8 mRNA in unstimulated cells exceeded 180 min and was not affected by EColCF ( figure 4) . Together, these data show that the protease activity of the EColCF medium is able to up-regulate IL-6 and IL-8 protein at the transcriptional level without affecting posttranscriptional mechanisms.
Proteases from A. fumigatus induce NF-kB and NF-IL6 DNA binding activities. Because EColCF was able to enhance the transcription of both IL-6 and IL-8 genes, we investigated DNA binding capacities of the transcription factors NF-kB, NF-IL6, and AP-1 by gel shift experiments. Potential binding sites of these transcription factors have been implicated in IL-6 and IL-8 promoter activation. A549 cells were stimulated with medium (control) or with EColCF for 2, 6, and 24 h. Nuclear extracts were analyzed for binding activity of NF-kB, NF-IL6, and AP-1. As shown in figure 5 , A549 cells cultured in medium alone showed very low levels of NF-kB binding activity. Culturing the cells with EColCF resulted in a time-dependent NFkB DNA binding. As early as 2 h after the addition of the EColCF-containing medium, NF-kB DNA binding was observed and increased further 6 h after addition of EColCFcontaining medium. Twenty-four hours after the addition of EColCF-containing medium, NF-kB DNA binding returned to control levels. NF-IL6 and AP-1 binding capacities were observed in control cells. As observed for NF-kB, EColCF enhanced the DNA binding capacities of NF-IL6 in a similar time-dependent fashion. In contrast, the constitutive DNA binding of AP-1 in control cells was slightly diminished on incubation with EColCF. Surprisingly, cells incubated for 24 h with EColCF showed an enhanced AP-1 DNA binding, compared with control levels. The specificity of the binding activities was determined by a 100-fold molar excess of unlabeled oligonucleotide to nuclear extracts of cells stimulated with EColCF (data not shown).
Proteases from A. fumigatus enhance IL-6 promoter activity. The protease-induced IL-6 gene transcription was investigated in more detail in A549 cells transiently transfected with 5 deletion constructs derived from the human IL-6 promoter linked to the luciferase reporter gene: pIL6luc(Ϫ602), pIL6luc(Ϫ298), and pIL6luc(Ϫ122). The results of the transfections showed that, in accordance with figure 3, protease activity of EColCF induced activity of the entire IL-6 promoter (figure 6). After transfection of the largest promoter construct pIL6luc(Ϫ602), which contains binding sites for AP-1, NF-IL6, and NF-kB, EColCF (5 mg/mL) enhanced the IL-6 promoter activity ( , ). After transfection of 1.92 ‫ע‬ 0.21 n = 3 P ! .02 pIL6luc(Ϫ298), which also contains the binding sites for AP- Figure 6 . Epithelial A549 cells were transiently transfected with the pIL6luc promoter construct with variable promoter lengths upstream of the luciferase reporter gene. pIL6luc(Ϫ602) and pIL6luc(Ϫ298) contain binding sites for nuclear factor (NF)-kB, NF-interleukin (IL)-6, and activator protein-1. pIL-6luc(Ϫ122) only contains the NF-kB binding site. pIL6( mut NF-kB) and pIL6( mut NF-IL6) have a point mutation in the NF-kB or in the NF-IL6 binding sequence, which prevents the DNA binding of the NF-kB and NF-IL6 proteins, respectively. The cells were incubated for 18 h with 5 mg/mL EcolCF. The bar diagram represents relative transcription rates compared with unstimulated cells, which were calculated after normalization to the respective levels of the cotransfected CAT activity. (*, ; #, ).
1, NF-IL6, and NF-kB, IL-6 promoter activity returned to control levels in A549 cells stimulated with EColCF. A similar inhibitory effect on the IL-6 promoter activity was observed when pIL6luc(Ϫ122), which merely contains the NF-kB binding site, was introduced into A549 cells. These results may imply as yet unidentified positive-regulatory cis-elements in the IL-6 promoter downstream from the AP-1 binding site within the region Ϫ298 through Ϫ602.
To further elucidate IL-6 gene transcription in A549 cells, pIL6luc( mut NF-kB) and pIL6luc( mut NF-IL6) were constructed. After transfection with the pIL-6luc( mut NF-kB), which is the largest IL-6 promoter construct containing a point mutation in the NF-kB binding site, the IL-6 promoter activity was significantly inhibited ( , ). Transfection of n = 3 P ! .05 pIL6luc( mut NF-IL6), which is the largest IL-6 promoter construct containing a point mutation in the NF-IL6 binding site, partially reduced EColCF-induced IL-6 promoter activity. These results indicate that NF-kB is a key regulator, together with an as yet unknown transcriptional regulator within the Ϫ298 through Ϫ602 promoter region, in IL-6 gene transcription in epithelial cells.
Discussion
Activated (primary) epithelial cells are able to secrete a variety of cytokines and growth factors. To elucidate mechanisms involved in this process, epithelial cells are generally activated by IL-1 and/or tumor necrosis factor (TNF) because these cytokines are potent inducers of the secretion of proinflammatory cytokines [20] [21] [22] . However, it is becoming increasingly evident that, in addition to cytokines and growth factors, proteases from different origins are able to elicit the release of proinflammatory cytokines by epithelial cells [10-13, 23, 24] . We have recently shown that culture filtrates from A. fumigatus dosedependently induced the release of IL-6 and IL-8 proteins by cultured epithelial cell lines, which could be inhibited by serine protease inhibitors, implicating the involvement of serine proteases released from A. fumigatus [13] . In our present report, we extended these observations. In the presence of EColCF, a culture filtrate of A. fumigatus containing high levels of protease activity, epithelial cells secreted both IL-6 and IL-8. The addition of antipain and chymostatin, which are both serine protease inhibitors, completely blocked the release of IL-6 and IL-8 proteins. In the present report, we further analyzed the mechanism(s) by which A. fumigatus-derived proteases cause the production of the proinflammatory cytokines IL-6 and IL-8. We showed that A. fumigatus-derived proteases enhanced the accumulation of IL-6 and IL-8 mRNA in comparison with unstimulated cells. After 6 h of stimulation with EColCF, the accumulation of both IL-6 and IL-8 mRNAs were enhanced approximately 2-fold and reached maximal levels after 112 h of stimulation.
In previous reports, it has been established that IL-6 and IL-8 gene expression by epithelial cell lines can be modulated at the transcriptional and posttranscriptional levels [20, 21] . Our transfection experiments show that proteases present in culture filtrates from A. fumigatus are able to induce the transcriptional activation of both the IL-6 and IL-8 genes, whereas the stability studies revealed that these proteases do not affect the posttranscriptional mRNA turnover rates. In the transcriptional regulation of IL-6 and IL-8 gene expression, the transcription factors NF-kB, NF-IL6, and AP-1 have been implicated, because putative consensus sequences of these transcription factors have been observed in the IL-6 [25, 26] and IL-8 promoters [21, 27, 28] . The involvement of both NF-kB and NF-IL6 in the EColCF-induced transcriptional regulation of IL-6 gene expression was shown in transfection experiments with the largest IL-6 promoter construct containing a mutated NF-kB site ( mut NF-kB) or a mutated NF-IL6 site ( moter-driven reporter gene transcription. In addition, electrophoretic mobility shift assays showed that unstimulated epithelial cells showed AP-1 binding activity, whereas NF-kB and NF-IL6 binding were not detectable. On stimulation with EColCF, binding activities of both NF-kB and NF-IL6 could be induced in a time-dependent manner. NF-kB and NF-IL6 binding capacities were optimal after 6 h of incubation with EColCF and slowly returned to control levels after 24 h of incubation with EColCF. In contrast, AP-1 binding activity was optimal after 24 h of incubation with EColCF. Therefore, spontaneous productions of IL-6 and IL-8 protein by epithelial cells may be driven predominantly by AP-1, whereas enhanced productions (112 h) result from an cooperative interplay of several transcription factors, including AP-1, NF-kB, and NF-IL6. Proteases inducing NF-kB activity may be responsible for the observed early gene expression of IL-6 and IL-8 and may be due to a receptor-mediated mechanism. Indeed, recent studies have shown the existence of a group of G-protein-coupled receptors on a variety of cells that are activated by endogenous proteases, designated proteinase-activated receptors (PARs); reviewed in [29] . Proteases activating the PARs involve receptor cleavage to expose a tethered ligand. Epithelial cells are able to specifically respond to proteases through activation of the protease-activated receptor 2. Activated PARs may up-regulate cellular functions, including cytokine secretion, cellular proliferation, and vascular tone. In addition, in smooth muscle cells, activation of the PAR-2 leads to phosphorylation of the mitogen-activated protein (MAP) kinases ERK-1/2 [30] . The latter may eventually lead to phosphorylation and enhanced transactivation capacity of NF-kB, which has also been shown in monocytic cells [31] . In addition to our study, it has recently been shown that the allergen Der p1, which also has protease activity, is capable of promoting the nuclear translocation of NF-kB in bronchial epithelial cells by an as yet unidentified mechanism [32, 33] , but a PAR may be involved. In the present study, we also showed that the EColCF-induced transcription of the IL-6 and IL-8 genes is abolished in the presence of the serine protease inhibitor chymostatin. Whether a PAR-involved mechanism is relevant in the transcriptional regulation of these genes in epithelial cells is, therefore, currently under investigation. It can also be speculated that endogenously produced cytokines have an effect on the observed transcriptional mechanisms involved in IL-6 and IL-8 gene expression. However, we were not able to inhibit the up-regulatory effect of EColCF on IL-6 and IL-8 protein secretions with antibodies against IL1b, GM-CSF, and TNF-a (unpublished observations), showing that protease-induced cytokine gene expression is a direct effect, independent from these epithelial cell-activating cytokines.
The observations that long exposure of epithelial cells to EColCF results in down-regulation of the binding capacities of both NF-kB and NF-IL6 and consequently to diminished production of IL-6 and IL-8 proteins may have important implications for the pathogenicity of A. fumigatus. By eliciting a cytokine response, the epithelium may signal the (mucosal) immune response. IL-6 and IL-8 are potent activators and/or chemoattractants for T lymphocytes and neutrophils [34, 35] , which help an organism to effectively deal with fungus infections. Down-regulation of these cytokines after longer exposure to A. fumigatus-derived proteases may result in a diminished infiltration of T cells and neutrophils and may thus contribute to the pathogenicity of this fungus. Support for this view may be obtained from the observation in biopsies that show A. fumigatus infections with neutrophil infiltrations but not in the direct vicinity of A. fumigatus [36] . The latter may be due to the diminished production of IL-8 by airway epithelial cells after longer exposure to proteases released by the fungi.
Taken together, in this study we showed that proteases released from A. fumigatus are able to enhance the production of IL-6 and IL-8 proteins by the airway-derived epithelial cell line A549 as a result of transcriptional mechanisms. Our findings in A549 cells may also be of relevance in vivo, because we have recently observed that primary epithelial cells also produce IL-6 and IL-8 subject to A. fumigatus proteases (manuscript in preparation).
